Working… Menu

Nivolumab in Patients With Recurrent Malignant Mesothelioma (NivoMes)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02497508
Recruitment Status : Completed
First Posted : July 14, 2015
Last Update Posted : September 14, 2017
Bristol-Myers Squibb
Information provided by (Responsible Party):
The Netherlands Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2017
Actual Study Completion Date : July 2017